December 23, 2013
1 min read
Save

Ultrasound measured subcutaneous compressibility to help diagnose eosinophilic fasciitis

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Eosinophilic fasciitis can be distinguished from diffuse systemic sclerosis by using B-mode ultrasound to measure subcutaneous compressibility, especially when tissue sampling is not feasible or its results are equivocal, researchers reported.

During a 4-year period, investigators used 12-MHz, B-mode ultrasound to evaluate the degree of subcutaneous compressibility (SC) in tissue in clinically involved forearm skin of 51 consecutive patients with eosinophilic fasciitis (EF; n=12), diabetic cheiroarthropathy (DMc; n=8), diffuse systemic sclerosis (dcSSc; n=23), and controls (n=8). These findings were compared with the standard of clinical diagnostic criteria for each disease process.

Among EF patients, median SC was 8.5%, significantly less than among dcSSc patients (29.6%; P<0.001).

When compared with dcSSc and controls, the SC in EF was reduced. Subcutaneous thinning was observed in 33% of EF, 50% of DMc and 26% of dcSSc patients, but not among controls. Less than 20% SC was observed in DMc and dcSSc patients with subcutaneous thinning. One EF patient had more than 20% compressibility, regardless of thinning.

“Our simple technique assessing subcutaneous tissue elasticity using a commonly available ultrasound unit may be more widely applicable in the clinic setting,” the investigators concluded.

Disclosure: The researchers report no relevant financial disclosures.